Cambridge University Hospitals NHS Foundation Trust · 1×
×1.619k/12kID
×1.21k/1kHI
×1.211k/10kEDM
×1.114k/13kIMMUN
×0.77k/9kHEMAT
Citations per year
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
'26
Countries citing scholars working at Oxford BioMedica (United Kingdom)
Since Specialization
Citations
This map shows the geographic impact of research produced by authors working at Oxford BioMedica (United Kingdom). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Oxford BioMedica (United Kingdom) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oxford BioMedica (United Kingdom) more than expected).
Fields of papers published by authors at Oxford BioMedica (United Kingdom)
This network shows the impact of papers affiliated with Oxford BioMedica (United Kingdom) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Oxford BioMedica (United Kingdom) at the time of their publication.
About Oxford BioMedica (United Kingdom)
In recent decades, authors affiliated with Oxford BioMedica (United Kingdom) have published 4.7k papers, which have received a total of 193.0k indexed citations . Scholars at this organization have produced 100 papers in Critical Care and Intensive Care Medicine, 226 papers in Hematology, 316 papers in Infectious Diseases, 539 papers in Epidemiology and 332 papers in Immunology on the topics of Asthma and respiratory diseases (132 papers), SARS-CoV-2 and COVID-19 Research (129 papers), Virus-based gene therapy research (124 papers), Immune Cell Function and Interaction (111 papers), Pleural and Pulmonary Diseases (104 papers), Pneumonia and Respiratory Infections (88 papers), Bacterial Infections and Vaccines (87 papers) and Acute Myeloid Leukemia Research (83 papers). Their work is cited by papers focused on Infectious Diseases (19.4k citations), Health Informatics (1.2k citations), Endocrinology, Diabetes and Metabolism (11.2k citations), Immunology (14.3k citations) and Hematology (6.7k citations). Authors at Oxford BioMedica (United Kingdom) collaborate with scholars in United Kingdom, United States and Netherlands and have published in prestigious journals including Nature Communications, BMJ Open, PLoS ONE, Scientific Reports and The Lancet. Some of Oxford BioMedica (United Kingdom)'s most productive authors include Andrew John Pollard, David Richard Matthews, Rury R. Holman, H. A. W. Neil, Mary Angelyn Bethel, Sanjoy Ketan Paul, Nicholas D. Mazarakis, Mark I. McCarthy, Ian Douglas Pavord and Fredrik Karpe.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.
Explore institutions with similar magnitude of impact